SweetValueLab
Write for us

Centene Corp. — Intrinsic Value & Fair Price

CNC
NYSEHealthcareMedical - Healthcare PlansCIK 0001071739centene.comAbout CNC
Valuation grade ?–not graded
Quant grade ?C
Last close · Oct 30, 202668.45−0.17 (−0.25%)

Valuation models

price $68.45 · as of Nov 2, 2026
EV/Revenue · peersused145.72 – 232.80170.1660% undervaluedWall St. consensus target—79.0013% belowCost of capital (WACC)—7.70%—

EV/Revenue · peers leads because DCF · Perpetuity growth · 5y could not lead: the cash-flow gate is shut (an operating loss, or three years of free cash flow summing below zero); P/E · peers does not describe this kind of business; EV/EBITDA · peers could not run on the filed statements. How the headline model is chosen.

engine build:07a9d3f952ed
Model value · EV/Revenue · peers
170.16
Centene closed at $68.45 — undervalued by 60% vs model.
145.72the model's range232.80

EV/Revenue · peers leads because DCF · Perpetuity growth · 5y could not lead: the cash-flow gate is shut (an operating loss, or three years of free cash flow summing below zero); P/E · peers does not describe this kind of business; EV/EBITDA · peers could not run on the filed statements. From its peers' median EV/Revenue.

Other models
—
Wall St. target
79.00 13% below
Below model, 1y
30 of 30 days

How it is valued

Valued asMature & stable
Moderate growth (~12% recent)Currently unprofitableHighly cyclical earningsStrong FCF yield (12.8%)
What growth the price implies: the reverse DCF

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.